Prostate Cancer - Results from #26540

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial - Abstract January 13, 2012

Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial - Abstract January 13, 2012

Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer - Abstract January 13, 2012

Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival January 13, 2012

Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: A contemporary series - Abstr January 12, 2012

The basis for monitoring strategies in clinical guidelines: A case study of prostate-specific antigen for monitoring in prostate cancer - Abstract January 12, 2012

Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer - Abstract January 12, 2012

Common structural and epigenetic changes in the genome of castration resistant prostate cancer - Abstract January 12, 2012

Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: A nation-wide survey in The Netherlands - Abstract January 12, 2012

The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy - Abstract January 12, 2012

Adjuvant radiotherapy following radical prostatectomy for prostate cancer - Abstract January 12, 2012

Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy - Abstract January 12, 2012

Association of 5α-reductase inhibitor use and pathological features of prostate cancer in men undergoing radical prostatectomy - Abstract January 12, 2012

Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer - Abstract January 12, 2012

Pseudolumen size and perimeter in prostate cancer: Correlation with patient outcome - Abstract January 11, 2012

The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi-center randomized trial - Abstract January 11, 2012

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer - Abstract January 11, 2012

Effect of endocrine treatment on voiding and prostate size in men with prostate cancer: A long-term prospective study - Abstract January 11, 2012

The role of resection of pulmonary metastases from prostate cancer: A case report and literature review - Abstract January 11, 2012

How to select the optimal therapy for early-stage prostate cancer - Abstract January 11, 2012

Page 1328 of 1437